|
⚲
|
| Keyboard |
| Garber Alan M
✚
|
|
|---|---|
| CIK # | 0001312907 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001312907] | |
| 4 | [0001312907] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Garber Alan M | |
| Vertex Pharmaceuticals Inc / Ma | |
| Exelixis Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2025-05-01 | Grant | 398 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2025-05-01 | Grant | 1,199 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2024-05-01 | Grant | 3,142 | $0.00 | |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2024-03-21 | Option exercise | 23,491 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2024-03-21 | Sell | 19,205 | $24.01 | 461,112 |
|
Exelixis Inc EXEL
Common Stock
|
2024-03-21 | Option exercise | 23,491 | $19.57 | 459,719 |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2023-06-01 | Grant | 44,087 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2023-05-01 | Grant | 1,741 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2023-05-01 | Grant | 584 | $0.00 | |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2023-02-21 | Option exercise | 40,000 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2023-02-21 | Option exercise | 40,000 | $6.30 | 252,000 |
|
Exelixis Inc EXEL
Common Stock
|
2023-02-21 | Sell | 40,000 | $17.49 | 699,600 |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2022-05-26 | Grant | 42,422 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2022-05-01 | Grant | 4,462 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2022-03-01 | Sell | 21,301 | $21.00 | 447,321 |
|
Exelixis Inc EXEL
Common Stock
|
2022-03-01 | Option exercise | 40,000 | $3.13 | 125,200 |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2022-03-01 | Option exercise | 40,000 | $0.00 | |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2021-05-27 | Grant | 33,549 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Stock Option (Right to Buy) · derivative
|
2021-05-01 | Grant | 6,067 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2021-03-15 | Option exercise | 40,000 | $3.38 | 135,200 |
| showing 20 of 70 most recent transactions | |||||